A causal role for hyperinsulinemia in obesity

Journal of Endocrinology

Volumn 232, Issue 3, 2017, Pages R173-R183

  Templeman, Nicole M ^a   Skovsø, Søs ^a   Page, Melissa M ^a   Lim, Gareth E ^a   Johnson, James D ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Institute for Personalized Therapeutic Nutrition   (Canada)

Author keywords

Diabetes; Insulin; Insulin resistance

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CELL EXPANSION; GENE LOCUS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; LIPID HOMEOSTASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT; OBESITY; PRIORITY JOURNAL; PROPHYLAXIS; WHITE ADIPOSE TISSUE; ANIMAL; BLOOD; COMPLICATION; HYPERINSULINISM; METABOLISM; PHYSIOLOGY;

ANIMALS; DIET, HIGH-FAT; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; OBESITY;

EID: 85014356791     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-16-0449     Document Type: Article

References (121)

1. Alemzadeh R, Jacobs W & Pitukcheewanont P 1996 Antiobesity effect of diazoxide in obese zucker rats. Metabolism 45 334-341. (doi: 10.1016/S0026-0495(96)90287-5)
2. Alemzadeh R, Langley G, Upchurch L, Smith P & Slonim AE 1998 Beneficial effect of diazoxide in obese hyperinsulinemic adults. Journal of Clinical Endocrinology and Metabolism 83 1911-1915. (10.1210/jc.83.6.1911)
3. Balkau B, Mhamdi L, Oppert JM, Nolan J, Golay A, Porcellati F, Laakso M, Ferrannini E & EGIR-RISC Study Group 2008 Physical activity and insulin sensitivity: the RISC study. Diabetes 57 2613-2618. (doi: 10.2337/db07-1605)
4. Banting FG, Best CH, Collip JB, Campbell WR & Fletcher AA 1922 Pancreatic extracts in the treatment of diabetes mellitus. Canadian Medical Association Journal 12 141-146.
5. Beith JL, Alejandro EU & Johnson JD 2008 Insulin stimulates primary beta-cell proliferation via Raf-1 kinase. Endocrinology 149 2251-2260. (doi: 10.1210/en.2007-1557)
6. Bengtsson M, Stahlberg A, Rorsman P & Kubista M 2005 Gene expression profiling in single cells from the pancreatic islets of Langerhans reveals lognormal distribution of mRNA levels. Genome Research 15 1388-1392. (doi: 10.1101/gr.3820805)
7. Beranger GE, Karbiener M, Barquissau V, Pisani DF, Scheideler M, Langin D & Amri EZ 2013 In vitro brown and 'brite'/'beige' adipogenesis: uman cellular models and molecular aspects. Biochimica et Biophysica Acta 1831 905-914. (doi: 10.1016/j.bbalip.2012.11.001)
8. Berglund ED, Li CY, Poffenberger G, Ayala JE, Fueger PT, Willis SE, Jewell MM, Powers AC & Wasserman DH 2008 Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes 57 1790-1799. (doi: 10.2337/db07-1615)
9. Bernal-Mizrachi E, Fatrai S, Johnson JD, Ohsugi M, Otani K, Han Z, Polonsky KS & Permutt MA 2004 Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. Journal of Clinical Investigation 114 928-936. (doi: 10.1172/JCI200420016)
10. Berry R, Jeffery E & Rodeheffer MS 2014 Weighing in on adipocyte precursors. Cell Metabolism 19 8-20. (doi: 10.1016/j.cmet.2013.10.003)
11. Biddinger SB & Kahn CR 2006 From mice to men: insights into the insulin resistance syndromes. Annual Review of Physiology 68 123-158. (doi: 10.1146/annurev.physiol.68.040104.124723)
12. Boothe T, Lim GE, Cen H, Skovso S, Piske M, Li SN, Nabi IR, Gilon P & Johnson JD 2016 Inter-domain tagging implicates caveolin-1 in insulin receptor trafficking and Erk signaling bias in pancreatic beta-cells. Molecular Metabolism 5 366-378. (doi: 10.1016/j.molmet.2016.01.009)
13. Boucher J, Mori MA, Lee KY, Smyth G, Liew CW, Macotela Y, Rourk M, Bluher M, Russell SJ & Kahn CR 2012 Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling. Nature Communications 3 902.
14. Brauner R, Serreau R, Souberbielle JC, Pouillot M, Grouazel S, Recasens C, Zerah M, Sainte-Rose C & Treluyer JM 2016 Diazoxide in children with obesity after hypothalamic-pituitary lesions: a randomized, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 101 4825-4833. (doi: 10.1210/jc.2016-2126)
15. Brogiolo W, Stocker H, Ikeya T, Rintelen F, Fernandez R & Hafen E 2001 An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Current Biology 11 213-221. (doi: 10.1016/S0960-9822(01)00068-9)
16. Buyken AE, Goletzke J, Joslowski G, Felbick A, Cheng G, Herder C & Brand-Miller JC 2014 Association between carbohydrate quality and inflammatory markers: systematic review of observational and interventional studies. American Journal of Clinical Nutrition 99 813-833. (doi: 10.3945/ajcn.113.074252)
17. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A & Lewis GF 1999 Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. American Journal of Physiology 276 E1055-E1066.
18. Cavallo-Perin P, Bruno A, Scaglione L, Gruden G, Cassader M & Pagano G 1993 Feedback inhibition of insulin and glucagon secretion by insulin is altered in abdominal obesity with normal or impaired glucose tolerance. Acta Diabetologica 30 154-158. (doi: 10.1007/BF00572860)
19. Cheng Z, Tseng Y & White MF 2010 Insulin signaling meets mitochondria in metabolism. Trends in Endocrinology and Metabolism 21 589-598. (doi: 10.1016/j.tem.2010.06.005)
20. Chondronikola M, Volpi E, Borsheim E, Porter C, Saraf MK, Annamalai P, Yfanti C, Chao T, Wong D, Shinoda K, et al. 2016 Brown adipose tissue activation is linked to distinct systemic effects on lipid metabolism in humans. Cell Metabolism 23 1200-1206. (doi: 10.1016/j.cmet.2016.04.029)
21. Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E, Leevers SJ & Partridge L 2001 Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292 104-106. (doi: 10.1126/science.1057991)
22. Cook A & Cowan C 2008 Adipose. In StemBook. Ed. The Stem Cell Research Community. Boston, MA, USA: Massachusetts General Hospital/Harvard Stem Cell Institute. (doi: 10.3824/stembook.1.40.1)
23. Corkey BE 2012 Banting lecture 2011: hyperinsulinemia: cause or consequence? Diabetes 61 4-13. (doi: 10.2337/db11-1483)
24. Cusin I, Terrettaz J, Rohner-Jeanrenaud F & Jeanrenaud B 1990 Metabolic consequences of hyperinsulinaemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver. Biochemical Journal 267 99-103.
25. Czech MP, Tencerova M, Pedersen DJ & Aouadi M 2013 Insulin signalling mechanisms for triacylglycerol storage. Diabetologia 56 949-964. (doi: 10.1007/s00125-013-2869-1)
26. Dankner R, Chetrit A, Shanik MH, Raz I & Roth J 2009 Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report. Diabetes Care 32 1464-1466. (doi: 10.2337/dc09-0153)
27. Deltour L, Leduque P, Blume N, Madsen O, Dubois P, Jami J & Bucchini D 1993 Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. PNAS 90 527-531. (doi: 10.1073/pnas.90.2.527)
28. Deltour L, Montagutelli X, Guenet JL, Jami J & Paldi A 1995 Tissue- and developmental stage-specific imprinting of the mouse proinsulin gene, Ins2. Developmental Biology 168 686-688. (doi: 10.1006/dbio.1995.1114)
29. Dionne DA, Skovso S, Templeman NM, Clee SM & Johnson JD 2016 Caloric restriction paradoxically increases adiposity in mice with genetically reduced insulin. Endocrinology 157 2724-2734. (doi: 10.1210/en.2016-1102)
30. Duvillie B, Bucchini D, Tang T, Jami J & Paldi A 1998 Imprinting at the mouse Ins2 locus: evidence for cis- and trans-allelic interactions. Genomics 47 52-57. (doi: 10.1006/geno.1997.5070)
31. Ebbeling CB, Leidig MM, Feldman HA, Lovesky MM & Ludwig DS 2007 Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial. JAMA 297 2092-2102. (doi: 10.1001/jama.297.19.2092)
32. Fan Y, Rudert WA, Grupillo M, He J, Sisino G & Trucco M 2009 Thymus-specific deletion of insulin induces autoimmune diabetes. EMBO Journal 28 2812-2824. (doi: 10.1038/emboj.2009.212)
33. Fernandez AM & Torres-Aleman I 2012 The many faces of insulinlike peptide signalling in the brain. Nature Reviews Neuroscience 13 225-239. (doi: 10.1038/nrn3209)
34. Fontana L, Partridge L & Longo VD 2010 Extending healthy life span - from yeast to humans. Science 328 321-326. (doi: 10.1126/science.1172539)
35. Fontes G, Zarrouki B, Hagman DK, Latour MG, Semache M, Roskens V, Moore PC, Prentki M, Rhodes CJ, Jetton TL, et al. 2010 Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass. Diabetologia 53 2369-2379. (doi: 10.1007/s00125-010-1850-5)
36. Fu Z, Gilbert ER & Liu D 2013 Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Current Diabetes Reviews 9 25-53. (doi: 10.2174/157339913804143225)
37. Fuente-Martin E, Argente-Arizon P, Ros P, Argente J & Chowen JA 2013 Sex differences in adipose tissue: it is not only a question of quantity and distribution. Adipocyte 2 128-134. (doi: 10.4161/adip.24075)
38. Genuth SM, Przybylski RJ & Rosenberg DM 1971 Insulin resistance in genetically obese, hyperglycemic mice. Endocrinology 88 1230-1238. (doi: 10.1210/endo-88-5-1230)
39. Gray SL, Donald C, Jetha A, Covey SD & Kieffer TJ 2010 Hyperinsulinemia precedes insulin resistance in mice lacking pancreatic B-cell leptin signaling. Endocrinology 151 4178-4186. doi: 10.1210/en.2010-0102)
40. Grosse J, Heffron H, Burling K, Akhter Hossain M, Habib AM, Rogers GJ, Richards P, Larder R, Rimmington D, Adriaenssens AA, et al. 2014 Insulin-like peptide 5 is an orexigenic gastrointestinal hormone. PNAS 111 11133-11138. (doi: 10.1073/pnas.1411413111)
41. Guerra C, Navarro P, Valverde AM, Arribas M, Bruning J, Kozak LP, Kahn CR & Benito M 2001 Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. Journal of Clinical Investigation 108 1205-1213. (doi: 10.1172/JCI13103)
42. Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ, et al. 2005 Loss of ARNT/HIF1beta mediates altered gene expression and pancreaticislet dysfunction in human type 2 diabetes. Cell 122 337-349. (doi: 10.1016/j.cell.2005.05.027)
43. Hatori M, Vollmers C, Zarrinpar A, DiTacchio L, Bushong EA, Gill S, Leblanc M, Chaix A, Joens M, Fitzpatrick JA, et al. 2012 Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metabolism 15 848-860. (doi: 10.1016/j.cmet.2012.04.019)
44. Hay CW & Docherty K 2006 Comparative analysis of insulin gene promoters: implications for diabetes research. Diabetes 55 3201-3213. (doi: 10.2337/db06-0788)
45. Holloszy JO 2005 Exercise-induced increase in muscle insulin sensitivity. Journal of Applied Physiology 99 338-343. (doi: 10.1152/japplphysiol.00123.2005)
46. Jeffery E, Wing A, Holtrup B, Sebo Z, Kaplan JL, Saavedra-Pena R, Church CD, Colman L, Berry R & Rodeheffer MS 2016 The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity. Cell Metabolism 24 142-150. (doi: 10.1016/j.cmet.2016.05.012)
47. Jeffrey KD, Alejandro EU, Luciani DS, Kalynyak TB, Hu X, Li H, Lin Y, Townsend RR, Polonsky KS & Johnson JD 2008 Carboxypeptidase E mediates palmitate-induced beta-cell ER stress and apoptosis. PNAS 105 8452-8457. (doi: 10.1073/pnas.0711232105)
48. Johnson AM & Olefsky JM 2013 The origins and drivers of insulin resistance. Cell 152 673-684. (doi: 10.1016/j.cell.2013.01.041)
49. Johnson JD, Bernal-Mizrachi E, Alejandro EU, Han Z, Kalynyak TB, Li H, Beith JL, Gross J, Warnock GL, Townsend RR, et al. 2006 Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. PNAS 103 19575-19580. (doi: 10.1073/pnas.0604208103)
50. Katic M, Kennedy AR, Leykin I, Norris A, McGettrick A, Gesta S, Russell SJ, Bluher M, Maratos-Flier E & Kahn CR 2007 Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice. Aging Cell 6 827-839. (doi: 10.1111/j.1474-9726.2007.00346.x)
51. Kenyon C, Chang J, Gensch E, Rudner A & Tabtiang R 1993 A C. elegans mutant that lives twice as long as wild type. Nature 366 461-464. (doi: 10.1038/366461a0)
52. Kersten S 2001 Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Reports 2 282-286. (doi: 10.1093/embo-reports/kve071)
53. Khan FA, Goforth PB, Zhang M & Satin LS 2001 Insulin activates ATP-sensitive K(+) channels in pancreatic beta-cells through a phosphatidylinositol 3-kinase-dependent pathway. Diabetes 50 2192-2198. (doi: 10.2337/diabetes.50.10.2192)
54. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF & Accili D 2000 Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. Journal of Clinical Investigation 105 199-205. (doi: 10.1172/JCI7917)
55. Knutson VP, Ronnett GV & Lane MD 1983 Rapid, reversible internalization of cell surface insulin receptors. Correlation with insulin-induced down-regulation. Journal of Biological Chemistry 258 12139-12142.
56. Kwok KH, Lam KS & Xu A 2016 Heterogeneity of white adipose tissue: molecular basis and clinical implications. Experimental and Molecular Medicine 48 e215. (doi: 10.1038/emm.2016.5)
57. Labbe SM, Caron A, Chechi K, Laplante M, Lecomte R & Richard D 2016 Metabolic activity of brown, 'beige,' and white adipose tissues in response to chronic adrenergic stimulation in male mice. American Journal of Physiology: Endocrinology and Metabolism 311 E260-E268. (10.1152/ajpendo.00545.2015)
58. Lawlor DA & Chaturvedi N 2006 Treatment and prevention of obesity - are there critical periods for intervention? International Journal of Epidemiology 35 3-9. (doi: 10.1093/ije/dyi309)
59. Le Stunff C & Bougnères P 1994 Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity. Diabetes 43 696-702.
60. Lee MJ, Wu Y & Fried SK 2013 Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Molecular Aspects of Medicine 34 1-11. (doi: 10.1016/j.mam.2012.10.001)
61. Lee SH, Zabolotny JM, Huang H, Lee H & Kim YB 2016 Insulin in the nervous system and the mind: functions in metabolism, memory, and mood. Molecular Metabolism 5 589-601. (doi: 10.1016/j.molmet.2016.06.011)
62. Leibiger IB, Leibiger B & Berggren PO 2008 Insulin signaling in the pancreatic beta-cell. Annual Review of Nutrition 28 233-251. (doi: 10.1146/annurev.nutr.28.061807.155530)
63. Leroux L, Desbois P, Lamotte L, Duvillie B, Cordonnier N, Jackerott M, Jami J, Bucchini D & Joshi RL 2001 Compensatory responses in mice carrying a null mutation for Ins1 or Ins2. Diabetes 50 (Supplement 1) S150-S153. (doi: 10.2337/diabetes.50.2007.S150)
64. Li C, Ford ES, McGuire LC, Mokdad AH, Little RR & Reaven GM 2006 Trends in hyperinsulinemia among nondiabetic adults in the U.S. Diabetes Care 29 2396-2402. (doi: 10.2337/dc06-0289)
65. Lim GE, Albrecht T, Piske M, Sarai K, Lee JT, Ramshaw HS, Sinha S, Guthridge MA, Acker-Palmer A, Lopez AF, et al. 2015 14-3-3zeta coordinates adipogenesis of visceral fat. Nature Communications 6 7671. (doi: 10.1038/ncomms8671)
66. Linde S, Nielsen JH, Hansen B & Welinder BS 1989 Reversed-phase highperformance liquid chromatographic analyses of insulin biosynthesis in isolated rat and mouse islets. Journal of Chromatography 462 243-254. (doi: 10.1016/S0021-9673(00)91351-7)
67. Longo VD & Panda S 2016 Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan. Cell Metabolism 23 1048-1059. (doi: 10.1016/j.cmet.2016.06.001)
68. Luciani DS & Johnson JD 2005 Acute effects of insulin on beta-cells from transplantable human islets. Molecular and Cellular Endocrinology 241 88-98. (doi: 10.1016/j.mce.2005.06.006)
69. Lunetta M, Di Mauro M, Le Moli R & Burrafato S 1996 Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans. Journal of Endocrinological Investigation 19 699-703. (doi: 10.1007/BF03349042)
70. Lustig RH, Greenway F, Velasquez-Mieyer P, Heimburger D, Schumacher D, Smith D, Smith W, Soler N, Warsi G, Berg W, et al. 2005 A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion. International Journal of Obesity 30 331-341. (doi: 10.1038/sj.ijo.0803074)
71. Marsh BD, Marsh DJ & Bergman RN 1986 Oscillations enhance the efficiency and stability of glucose disposal. American Journal of Physiology 250 E576-E582.
72. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA & Duncan AW 2001 Diagnosing insulin resistance in the general population. Diabetes Care 24 460-464.
73. McCarthy MI 2015 Genomic medicine at the heart of diabetes management. Diabetologia 58 1725-1729. (doi: 10.1007/s00125-015-3588-6)
74. McCormack SE, Shaham O, McCarthy MA, Deik AA, Wang TJ, Gerszten RE, Clish CB, Mootha VK, Grinspoon SK & Fleischman A 2013 Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatric Obesity 8 52-61. (doi: 10.1111/j.2047-6310.2012.00087.x)
75. McGarry JD 1992 What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258 766-770. (doi: 10.1126/science.1439783)
76. Mehran AE, Templeman NM, Brigidi GS, Lim GE, Chu KY, Hu X, Botezelli JD, Asadi A, Hoffman BG, Kieffer TJ, et al. 2012 Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metabolism 16 723-737. (doi: 10.1016/j.cmet.2012.10.019)
77. Melloul D, Marshak S & Cerasi E 2002 Regulation of insulin gene transcription. Diabetologia 45 309-326. (doi: 10.1007/s00125-001-0728-y)
78. Meur G, Qian Q, da Silva Xavier G, Pullen TJ, Tsuboi T, McKinnon C, Fletcher L, Tavare JM, Hughes S, Johnson P, et al. 2011 Nucleo-cytosolic shuttling of FoxO1 directly regulates mouse Ins2 but not Ins1 gene expression in pancreatic beta cells (MIN6). Journal of Biological Chemistry 286 13647-13656. (doi: 10.1074/jbc.M110.204248)
79. Nair KS & Short KR 2005 Hormonal and signaling role of branched-chain amino acids. Journal of Nutrition 135 1547S-1552S.
80. Nakae J, Kido Y & Accili D 2001 Distinct and overlapping functions of insulin and IGF-I receptors. Endocrine Reviews 22 818-835. (doi: 10.1210/edrv.22.6.0452)
81. Nelson RK, Horowitz JF, Holleman RG, Swartz AM, Strath SJ, Kriska AM & Richardson CR 2013 Daily physical activity predicts degree of insulin resistance: a cross-sectional observational study using the 2003-2004 National Health and Nutrition Examination Survey. International Journal of Behavioral Nutrition and Physical Activity 10 10. (doi: 10.1186/1479-5868-10-10)
82. Nolan CJ, Damm P & Prentki M 2011 Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378 169-181. (doi: 10.1016/S0140-6736(11)60614-4)
83. Nolan CJ, Ruderman NB & Prentki M 2013 Intensive insulin for type 2 diabetes: the risk of causing harm. Lancet Diabetes and Endocrinology 1 9-10. (doi: 10.1016/S2213-8587(13)70027-5)
84. Nolan CJ, Ruderman NB, Kahn SE, Pedersen O & Prentki M 2015 Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes. Diabetes 64 673-686. (doi: 10.2337/db14-0694)
85. O'Rahilly S, Turner RC & Matthews DR 1988 Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. New England Journal of Medicine 318 1225-1230. (10.1056/nejm198805123181902)
86. Odeleye OE, de Courten M, Pettitt DJ & Ravussin E 1997 Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 46 1341-1345. (doi: 10.2337/diab.46.8.1341), ORIGIN Trial Investigators
87. Gerstein HC, Bosch J, Dagenais GR, Diaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, et al. 2012 Basal insulin and cardiovascular and other outcomes in dysglycemia. New England Journal of Medicine 367 319-328. (doi: 10.1056/NEJMoa1203858)
88. Paolisso G, Gambardella A, Amato L, Tortoriello R, D'Amore A, Varricchio M & D'Onofrio F 1995 Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38 1295-1299. (doi: 10.1007/BF00401761)
89. Pedersen DJ, Guilherme A, Danai LV, Heyda L, Matevossian A, Cohen J, Nicoloro SM, Straubhaar J, Noh HL, Jung D, et al. 2015 A major role of insulin in promoting obesity-associated adipose tissue inflammation. Molecular Metabolism 4 507-518. (doi: 10.1016/j.molmet.2015.04.003)
90. Pierce SB, Costa M, Wisotzkey R, Devadhar S, Homburger SA, Buchman AR, Ferguson KC, Heller J, Platt DM, Pasquinelli AA, et al. 2001 Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes and Development 15 672-686. (doi: 10.1101/gad.867301)
91. Pittas AG, Das SK, Hajduk CL, Golden J, Saltzman E, Stark PC, Greenberg AS & Roberts SB 2005 A low-glycemic load diet facilitates greater weight loss in overweight adults with high insulin secretion but not in overweight adults with low insulin secretion in the CALERIE trial. Diabetes Care 28 2913-2941.
92. Prentki M & Nolan CJ 2006 Islet beta cell failure in type 2 diabetes. Journal of Clinical Investigation 116 1802-1812. (doi: 10.1172/JCI29103)
93. Rajan S, Shankar K, Beg M, Varshney S, Gupta A, Srivastava A, Kumar D, Mishra RK, Hussain Z, Gayen JR, et al. 2016 Chronic hyperinsulinemia reduces insulin sensitivity and metabolic functions of brown adipocyte. Journal of Endocrinology 230 275-290. (doi: 10.1530/JOE-16-0099)
94. Rideout EJ, Narsaiya MS & Grewal SS 2015 The sex determination gene transformer regulates male-female differences in Drosophila body size. PLoS Genetics 11 e1005683. (doi: 10.1371/journal.pgen.1005683)
95. Robertson RP 2007 Estimation of beta-cell mass by metabolic tests: necessary, but how sufficient? Diabetes 56 2420-2424. (doi: 10.2337/db07-0742)
96. Saltiel AR & Kahn CR 2001 Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 799-806. (doi: 10.1038/414799a)
97. Satin LS, Butler PC, Ha J & Sherman AS 2015 Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes. Molecular Aspects of Medicine 42 61-77. (doi: 10.1016/j.mam.2015.01.003)
98. Schugar RC & Crawford PA 2012 Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease. Current Opinion in Clinical Nutrition and Metabolic Care 15 374-380. (doi: 10.1097/MCO.0b013e3283547157)
99. Schwartz MW & Porte D Jr 2005 Diabetes, obesity, and the brain. Science 307 375-379. (doi: 10.1126/science.1104344)
100. Shabanpoor F, Separovic F & Wade JD 2009 The human insulin superfamily of polypeptide hormones. Vitamins and Hormones 80 1-31. (10.1016/s0083-6729(08)00601-8)
101. Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y & Roth J 2008 Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31 (Supplement 2) S262-S268. (doi: 10.2337/dc08-s264)
102. Shiao MS, Liao BY, Long M & Yu HT 2008 Adaptive evolution of the insulin two-gene system in mouse. Genetics 178 1683-1691. (doi: 10.1534/genetics.108.087023)
103. Skovso S, Damgaard J, Fels JJ, Olsen GS, Wolf XA, Rolin B & Holst JJ 2015 Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes. International Journal of Obesity 39 1531-1538.
104. Soares MB, Schon E, Henderson A, Karathanasis SK, Cate R, Zeitlin S, Chirgwin J & Efstratiadis A 1985 RNA-mediated gene duplication: the rat preproinsulin I gene is a functional retroposon. Molecular and Cellular Biology 5 2090-2103. (doi: 10.1128/MCB.5.8.2090)
105. Softic S, Boucher J, Solheim MH, Fujisaka S, Haering MF, Homan EP, Winnay J, Perez-Atayde AR & Kahn CR 2016 Lipodystrophy due to adipose tissue specific insulin receptor knockout results in progressive NAFLD. Diabetes 65 2187-2200. (doi: 10.2337/db16-0213)
106. Staaf J, Ubhayasekera SJ, Sargsyan E, Chowdhury A, Kristinsson H, Manell H, Bergquist J, Forslund A & Bergsten P 2016 Initial hyperinsulinemia and subsequent beta-cell dysfunction is associated with elevated palmitate levels. Pediatric Research 80 267-274. (doi: 10.1038/pr.2016.80)
107. Stockhorst U, de Fries D, Steingrueber HJ & Scherbaum WA 2004 Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans. Physiology and Behavior 83 47-54. (doi: 10.1016/S0031-9384(04)00348-8)
108. Szabat M, Lynn FC, Hoffman BG, Kieffer TJ, Allan DW & Johnson JD 2012 Maintenance of beta-cell maturity and plasticity in the adult pancreas: developmental biology concepts in adult physiology. Diabetes 61 1365-1371. (doi: 10.2337/db11-1361)
109. Szabat M, Page MM, Panzhinskiy E, Skovso S, Mojibian M, Fernandez-Tajes J, Bruin JE, Bround MJ, Lee JT, Xu EE, et al. 2016 Reduced insulin production relieves endoplasmic reticulum stress and induces beta cell proliferation. Cell Metabolism 23 179-193. (doi: 10.1016/j.cmet.2015.10.016)
110. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M & Witte DR 2009 Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373 2215-2221. (doi: 10.1016/S0140-6736(09)60619-X)
111. Taniguchi CM, Emanuelli B & Kahn CR 2006 Critical nodes in signalling pathways: insights into insulin action. Nature Reviews Molecular Cell Biology 7 85-96. (doi: 10.1038/nrm1837)
112. Templeman NM, Clee SM & Johnson JD 2015 Suppression of hyperinsulinaemia in growing female mice provides long-term protection against obesity. Diabetologia 58 2392-2402. (doi: 10.1007/s00125-015-3676-7)
113. Templeman NM, Mehran AE & Johnson JD 2016 Hyper-variability in circulating insulin, high fat feeding outcomes, and effects of reducing Ins2 dosage in male Ins1-null mice in a specific pathogen-free facility. PLoS ONE 11 e0153280. (doi: 10.1371/journal.pone.0153280)
114. Thorens B, Tarussio D, Maestro MA, Rovira M, Heikkila E & Ferrer J 2015 Ins1(Cre) knock-in mice for beta cell-specific gene recombination. Diabetologia 58 558-565. (doi: 10.1007/s00125-014-3468-5)
115. van Heemst D 2010 Insulin, IGF-1 and longevity. Aging and Disease 1 147-157.
116. van Loon LJ, Kruijshoop M, Menheere PP, Wagenmakers AJ, Saris WH & Keizer HA 2003 Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care 26 625-630. (doi: 10.2337/diacare.26.3.625)
117. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, et al. 2011 Metabolite profiles and the risk of developing diabetes. Nature Medicine 17 448-453. (doi: 10.1038/nm.2307)
118. Wang M, Li J, Lim GE & Johnson JD 2013 Is dynamic autocrine insulin signaling possible? A mathematical model predicts picomolar concentrations of extracellular monomeric insulin within human pancreatic islets. PLoS ONE 8 e64860. (doi: 10.1371/journal.pone.0064860)
119. Wentworth BM, Schaefer IM, Villa-Komaroff L & Chirgwin JM 1986 Characterization of the two nonallelic genes encoding mouse preproinsulin. Journal of Molecular Evolution 23 305-312. (doi: 10.1007/BF02100639)
120. Werner H, Weinstein D & Bentov I 2008 Similarities and differences between insulin and IGF-I: structures, receptors, and signalling pathways. Archives of Physiology and Biochemistry 114 17-22. (doi: 10.1080/13813450801900694)
121. White MF 2003 Insulin signaling in health and disease. Science 302 1710-1711. (doi: 10.1126/science.1092952)